Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS
Completed · Phase 3 · NCT02730299
Conditions: Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Chronic Myelogenous Leukemia (CML), Myelodysplastic Syndrome (MDS), Lymphoma, Acute Leukemia
At a glance
- Research payments reported, 2025
- $97,189
- U.S. investigators named
- 5
- Sites paid
- 5
- Planned or actual enrollment
- 125
About the trial
- Sponsor
- Gamida Cell ltd
- Tested
- NiCord® (omidubicel) (drug), Cord Blood Unit (other)
- Dates
- Started 2016-12-16; completion 2025-02-07
- Results posted
- Yes
This study is an open-label, controlled, multicenter, international, Phase III, randomized study of transplantation of NiCord® versus transplantation of one or two unmanipulated, unrelated cord blood units in patients with acute lymphoblastic leukemia or acute myeloid leukemia, myelodysplastic syndrome, chronic myeloid leukemia or lymphoma, all with required disease features rendering them eligible for allogeneic transplantation.
From ClinicalTrials.gov, last updated 2026-02-25. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Gamida Cell Inc. reported $97,189 in research payments for this study in 2025 (7 payments).
Products named: Omisirge
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Michael Verneris, MD Pediatric Hematology & Oncology · Aurora, CO
- Kehinde Adekola, MD Hematology & Oncology · Chicago, IL
- Joseph P. Mcguirk, D.O. Hematology & Oncology · Kansas City, KS
- John E. Wagner, MD Pediatric Hematology & Oncology · Minneapolis, MN
- Richard T. Maziarz, MD Hematology · Portland, OR
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Northwestern University $36,500
- Ohsu Hospital and Clinics, OR $30,715
- Regents of the University of Minnesota $26,533
- University of Kansas Medical Center Research $2,099
- Children's Hospital Colorado, CO $1,343
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.